TY - JOUR
T1 - Autophagy in acute brain injury
AU - Galluzzi, Lorenzo
AU - Bravo-San Pedro, José Manuel
AU - Blomgren, Klas
AU - Kroemer, Guido
N1 - Publisher Copyright:
© 2016 Macmillan Publishers Limited.
PY - 2016/7/19
Y1 - 2016/7/19
N2 - Autophagy is an evolutionarily ancient mechanism that ensures the lysosomal degradation of old, supernumerary or ectopic cytoplasmic entities. Most eukaryotic cells, including neurons, rely on proficient autophagic responses for the maintenance of homeostasis in response to stress. Accordingly, autophagy mediates neuroprotective effects following some forms of acute brain damage, including methamphetamine intoxication, spinal cord injury and subarachnoid haemorrhage. In some other circumstances, however, the autophagic machinery precipitates a peculiar form of cell death (known as autosis) that contributes to the aetiology of other types of acute brain damage, such as neonatal asphyxia. Here, we dissect the context-specific impact of autophagy on non-infectious acute brain injury, emphasizing the possible therapeutic application of pharmacological activators and inhibitors of this catabolic process for neuroprotection.
AB - Autophagy is an evolutionarily ancient mechanism that ensures the lysosomal degradation of old, supernumerary or ectopic cytoplasmic entities. Most eukaryotic cells, including neurons, rely on proficient autophagic responses for the maintenance of homeostasis in response to stress. Accordingly, autophagy mediates neuroprotective effects following some forms of acute brain damage, including methamphetamine intoxication, spinal cord injury and subarachnoid haemorrhage. In some other circumstances, however, the autophagic machinery precipitates a peculiar form of cell death (known as autosis) that contributes to the aetiology of other types of acute brain damage, such as neonatal asphyxia. Here, we dissect the context-specific impact of autophagy on non-infectious acute brain injury, emphasizing the possible therapeutic application of pharmacological activators and inhibitors of this catabolic process for neuroprotection.
UR - http://www.scopus.com/inward/record.url?scp=84973154826&partnerID=8YFLogxK
U2 - 10.1038/nrn.2016.51
DO - 10.1038/nrn.2016.51
M3 - Review article
C2 - 27256553
AN - SCOPUS:84973154826
SN - 1471-003X
VL - 17
SP - 467
EP - 484
JO - Nature Reviews Neuroscience
JF - Nature Reviews Neuroscience
IS - 8
ER -